Explore how topical PDE4 inhibition treatments offer a more targeted approach to treating atopic dermatitis compared to systemic options
How is PDE4 involved in the pathophysiology of atopic dermatitis?
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
This content has been developed independently of the sponsors who have had no editorial input into the content. Medthority received educational funding from the sponsor Pfizer in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.